The aim of this study was to detect simultaneously four lung cancer biomarkers: CYFRA 21-1, CEA, NSE and HER-1, from blood samples. In order to do that, we have chosen stochastic senosors based on diamond paste matrices modified with different electroactive materials like dextrins and porphyrins, and ones based on three metals like Au, Cu and Ni. The stochastic sensors chosen for the screening tests of blood samples proved to be a good choice for the simultaneous detection of the four biomarkers, reaching low limits of determination of pg mL −1 magnitude order and high sensitivities. One main advantage of the sensors used for the simultaneous detection of the biomarkers is that the samples are analyzed as taken from the patients, without any pretreatment. © 2017 The Electrochemical Society. [DOI: 10.1149/2.1621706jes] All rights reserved.
According to the latest report of the American Cancer Society an estimated 224.390 new cases of lung cancer are expected in 2016, accounting for about 14% of all cancer diagnoses. Lung cancer is the second most commonly diagnosed cancer and accounts for more deaths than any other cancer in both men and women with an estimated 158.080 deaths that are expected to occur in 2016, accounting for about 1 in 4 cancer deaths. 1 Despite advances in the understanding of tumor biology in recent years, lung cancer mortality in Europe has remained largely unchanged over the past three decades, underlying the need for new treatment strategies. 2 Lung cancer at its early stage is mostly asymptomatic in most cases that make early diagnosis difficult. The current detection and diagnosis for lung cancer include physical and biochemical methods. The physical methods include X-ray, CT (Computed Tomography), PET (Positron Emission Tomography), bronchoscopy, sputum cytology and bronchial biopsy, none of which turns out to be effective in early diagnosis of lung cancer. However, ability to use these techniques is dependent on the size of tumor and some special medical equipment, leading to a increasingly cost. Several biochemical methods for the detection of lung cancer are also used clinically by detecting biomarkers released by cancer cells or lung tumors into the serum/plasma/blood. The biochemical methods are less invasive and cost-effective. [3] [4] [5] Among the currently lung cancer biomarkers used for the screening, diagnosis and detection of lung cancer are neuron specific enolase (NSE), carcinoembryonic antigen (CEA), epidermal growth factor receptor (HER-1/EGFR), cytokeratin 19 fragment (CYFRA 21-1), tumor M2 pyruvate kinase (PKM2), pro-gastrin-releasing peptide (Pro-GRP), squamous cell carcinoma antigen (SCC-Ag), tissue polypeptide antigen (TPA) and tissue polypeptide-specific antigen (TPS). [6] [7] [8] [9] [10] [11] To date, the analysis of the biomarkers has been performed with enzyme-linked immunosorbent assay (ELISA), 10, [12] [13] [14] electrochemiluminescence immunoassay (ECLIA), 15 radioimmunoassay (RIA), [16] [17] [18] imunoradiometric assay (IRMA), 10, 19 fluorescence in situ hybridization (FISH) 20 or polymerase chain reaction (PCR). 21 These conventional well-developed methods analyze each analyte individually and require significant sample volumes for each analyte, measure single analytes per assay and are not well suited for highthroughput multiplex analysis. 22 For this reason, in the recent years the development of new methods and materials used for the assay of biomarkers has known a well defined improvement, with minimally invasive procedures and with highly sensitive and specific detection. Current systems employed for the detection of cancer biomarkers include the fabrication of different kinds of electrochemical immunosensors 23 based on gold nanocrystals (AuNCs), 24 gold nanoparticles (AuNPs), [25] [26] [27] β-cyclodextrin functionalized Cu@Ag (Cu@Ag-CD) core-shell nanoparticles, 28 or different devices like an aptamer based on gold electrodes, 29 a multi-target immunosensig lab-on-chip, 30 or a field effect transistor (FET)-based biosensor.
31 Table I summarizes the current investigations on lung cancer diagnosis using sensors. The table also lists the biomarkers tested with the corresponding detection limits and linear concentration ranges.
Our goal was to establish a method based on stochastic sensing for the simultaneous detection of four lung cancer biomarkers: NSE, CEA, HER-1 and CYFRA 21-1. For this, we proposed various stochastic sensors based on diamond paste modified with different dextrines, porphyrins, as well as stochastic sensors based on metallic materials like gold, nickel and copper.
Experimental
Reagents and materials.-Epidermal growth factor receptor (EGFR/HER-1), carcinoembryonic antigen (CEA), neuron specific enolase (NSE), natural diamond powder (DP) having paticle size of 1 μm (99.9%), maltodextrin I (MD I) with dextrose equivalent 4-7, maltodextrin III (MD III) with dextrose equivalent 16.5-19.5, 5,10,15,20-tetraphenyl-21H,23H-porphyrin (P), monosodium and disodium phosphate were purchased from Sigma Aldrich (Milwaukee, USA). CYFRA 21-1 (a human cytokeratin 19 protein) was purchased from Abcam (Massachusetts, USA). Paraffin oil and NaN 3 were purchased from Fluka (Buchs, Switzerland). α-cyclodextrin was supplied by Wacher-Chemie GmbH (Germany). Monosodium phosphate and disodium phosphate were used for preparation of phosphate buffer. Deionized water obtained from a Millipore Direct-Q 3 System (Molsheim, France) was used for the preparation of all solutions. The standard solutions of NSE were all prepared in phosphate buffer solution (pH = 7.04). The range of concentrations was obtained by serial dilution method from 7.449 pg mL −1 to 0.125 mg mL −1 . The standard solutions of CEA and HER-1 were prepared in buffer solution pH = 7.4, containing NaN 3 0,1%. Serial dilution technique was used for the preparation of solutions of CEA in the range 16 pg mL −1 -16 mg mL −1 and HER-1 in the range 0.56 pg mL −1 -3.04 μg mL −1 . All CYFRA 21-1 standard solutions were prepared in deionized water in a range of concentrations obtained by serial dilution method from 0.002 pg mL −1 to 20 μg mL −1 . Engineered nanoporous 24 K gold microspheres, thin copper and nickel nanofilms were designed by a team of NILPRP. Instrumentation.-For all chronoamperometric experiments was used a PGSTAT 12 potentiostat/galvanostat connected to a threeelectrode cell, and linked to a computer via an Eco Chemie (Utretch, The Netherlands) software version 4.9. The electrochemical cell was assembled with a conventional three electrode cell: the working electrode, an Ag/AgCl (0,1 mol/1 KCl) as reference electrode and a Pt counter electrode. For the pH measurements was used a Cyberscan PCD 6500 pH/mV-meter from Eutech Instruments.
Design of the stochastic sensors.-Modified diamond pastes (DP) were prepared as follows: 200 mg of natural monocrystalline diamond powder was mixed with 20 μL paraffin oil to form a paste. 100 μL from the 10 −3 mol/L solution of maltodextrin I (dextrose equivalent 4-7) or maltodextrin III (dextrose equivalent 16.5-19.5) was added to the diamond paste. 50 μL from the 10 −3 mol/L solution of the electrochemical active compound (α-cyclodextrin or 5,10,15,20-tetraphenyl-21H,23H-porphyrin) were added to each 100 mg of paste. The modified paste was placed into a plastic tube with a diameter of 25 μm. Electric contact was obtained by inserting an Ag wire into the modified paste. The surface of the sensor was wetted with deionized water and polished with alumina paper before using. When not in use, the sensors were stored in a dry place at room temperature.
One nanoporous gold microsphere of a diameter of 300 μm was placed in a plastic tube so that hath of the sphere was out and the other hath inside the tube. Electrical contact was done using a silver wire.
The textile sensors based on Cu, and Ni nanofilms, were prepared using a piece of nickel or copper coated textile with a length of 2.5 cm and a width of 1.0 mm connected directly to the external circuit.
Stochastic method.-For the stochastic sensing, a chronoamperometric technique was selected for the measurements of t on and t off when a potential of 125 mV versus Ag/AgCl was applied. The electrodes were dipped into a cell containing standard solutions of different concentrations of of analyte. Equations of calibration 1/t on = f(Conc.) are determined using statistics (linear regression equation). The unknown concentrations of the four biomarkers in blood samples were determined by inserting the value of 1/t on in the equation of calibration.
Sample preparation.-Universitary Hospital from Bucharest provided us whole blood samples from patients that were diagnosed with lung cancer, or from patients that were suspected of lung malignancies (Ethics committee approval nr. 11/2013, informed consent was obtained from all subjects) in order to use them for the screening of the four biomarkers. The samples were used for the screening of the lung cancer biomarkers without any pretreatment. The apparatus cell was filled with whole blood sample and the unknown concentration of the biomarker in whole blood samples were determined using the stochastic method.
Results and Discussion
Response characteristics of the stochastic sensors proposed for the screening of the lung cancer biomarkers.-The principle of stochastic sensors is based on the alteration of electrical current by distinct analytes that interact transiently or permanently with a functional recognition group located within a nanopore. In the absence of compounds, the nanopore is always open and a constant ionic current is observed. In the presence of an analyte, when this is entering the pore, is blocking partially or totally, and the intensity of the current is also dropping to zero (t off ) -the value measured for the time off is giving the qualitative identification of the analyte, while the time spend in the pore for binding and redox processes (t on ) is giving the concentration of the analyte. In the case of the lung cancer biomarkers the following reactions are taking place:
where Ch represents the channel and i the interface.
Response characteristics of the stochastic sensors proposed for the detection of NSE, CEA, HER-1 reported previously [33] [34] [35] [36] [37] as well as the response characteristics obtained for CYFRA 21-1 are shown in Tables II and III . The sensors based on diamond paste showed good response characteristics, high values of sensitivity and low limits of determination. The sensor based on P/DP has exhibit the best response among all the diamond paste sensors with limits of determination of pg mL −1 magnitude order for all studied biomarkers: 477 pg mL −1 for NSE, 1.6 pg mL −1 for CEA, 7 pg mL −1 for HER-1 and for CYFRA 21-1 has reached a limit of determination of 0.002 pg mL −1 (Table II) . Among the sensors based on metals, the one based on Ni gave the best response for CEA and HER-1, the calibration plots showed a good linear relationship between the values of 1/t on and the analyte concentrations in the ranges from 0.016 to 16 pg mL −1 for CEA and 0.28-7 pg mL −1 for HER-1, respectively. The Cu based sensor exhibited a good linear response in the range from 1.91 to 488 ng mL −1 for NSE and 20 pg mL −1 -2 ng mL −1 for CYFRA 21-1 respectively (Table III) .
All the sensors proposed were stable over a period of six months, when used daily for measurements. No significant differences in stability were recorded for the proposed sensors, proving that in this case the type of modifier, matrix or metal used did not influenced the stability. Furthermore, five sensors of each category were constructed and used daily for one month, when the RSD(%) values for their slopes did not varied with more than 1.00%, proving the reliability of the design.
The selectivity of the sensors was proved by the different signatures (t off values) obtained for each biomarker when the same sensor was Table IV . Results of screening tests of whole blood samples for NSE, CEA, HER-1 and CYFRA 21-1.
Sample Nr
Microsensor based on CEA (ng/mL) NSE (ng/mL) HER-1 (ng/mL) CYFRA 21-1 (ng/mL) used. Ascorbic acid was also given a diferent signature, proving that it is not interfering in the mesurements.
Analytical applications.-In order to evaluate the practical application of the stochastic sensors proposed for the simultaneous detection of NSE, CEA, HER-1 and CYFRA 21 we analyzed a total of 13 whole blood samples. Thus, we identified all the four biomarkers from the whole blood samples based on the signatures of the biomarkers (t off values), and their concentration was calculated based on the t on values (Figs. 1, 2) . The values of t on were measured and calculated from the calibration graph in order to determine the concentration of the four biomarkers (Table IV) . The control sample was obtained from a healty patient; none of the biomarkers was identified in the whole blood sample of the patient.
Recovery tests.-A recovery test was performed using the proposed sensors for CYFRA 21-1. The concentrations determined from the calibration graphs accordingly with the proposed method, were compared with the theoretical concentrations of the spiked whole blood samples. As it was showen in Table V the recoveries were higher than 93.00%. Recoveries for NSE, CEA, and HER-1 were demonstrated previously.
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Conclusions
In this study CYFRA 21-1 was added to the previously tested biomarkers in order to get a complete screening test for lung cancer. The sensors proposed showed very good analytical performances for the measurement of NSE, CEA, HER-1 and CYFRA 21-1 with wide concentration linear range, low determination limits, good sensitivity, reproducibility and stability, thus providing promising tools for the simultaneous detection in early clinical diagnosis. All the sensors have been successfully applied for the simultaneous detection of NSE, CEA, HER-1 and CYFRA 21-1 from whole blood samples. Compared with the sensors proposed previously in the literature, one can find the following advantages of using the stochastic sensors: the sample did not need any processing, the limits of determinations are far lower, the sensitivity is higher, and all four biomarkers can be determined using the same sensors in one run.
